We updated the design of this site on September 25th. Learn more.
Show more

Glossary Definition

A process regulated by the Food and Drug Administration (FDA) that allows manufacturers to provide investigational new drugs to patients with serious diseases or conditions who cannot participate in a clinical trial. One of several Study Types.

For more information on expanded access, visit the Expanded Access: Information for Patients page on the FDA Web site.